MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
0.7975
+0.0311
+4.06%
After Hours: 0.8199 +0.0224 +2.81% 19:55 12/18 EST
OPEN
0.7850
PREV CLOSE
0.7664
HIGH
0.8935
LOW
0.7850
VOLUME
2.75M
TURNOVER
--
52 WEEK HIGH
1.800
52 WEEK LOW
0.3067
MARKET CAP
46.64M
P/E (TTM)
-1.1078
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 13h ago
Femasys Gains FDA Clearance for FemVue Diagnostic Device
TipRanks · 19h ago
Femasys secures U.S. FDA clearance for FemVue Controlled device
TipRanks · 20h ago
Femasys Receives 510(k) Clearance From FDA For FemVue Controlled Device, Diagnostic Solution For Controlled Contrast Delivery To Evaluate Fallopian Tube Status
Benzinga · 20h ago
Femasys Secures FDA Clearance for Next-Generation FemVue Controlled Device
Reuters · 20h ago
Weekly Report: what happened at FEMY last week (1208-1212)?
Weekly Report · 4d ago
Weekly Report: what happened at FEMY last week (1201-1205)?
Weekly Report · 12/08 09:29
Weekly Report: what happened at FEMY last week (1124-1128)?
Weekly Report · 12/01 09:27
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.